W. Qureshi et S. Rashid, ZOLLINGER-ELLISON-SYNDROME - IMPROVED TREATMENT OPTIONS FOR THIS COMPLEX DISORDER, Postgraduate medicine, 104(1), 1998, pp. 155
Zollinger-Ellison syndrome is a rare disorder characterized by severe
peptic ulcer disease, gastric acid hypersecretion, and non-beta islet
cell tumors of the pancreas. Most gastrinomas are found within an anat
omic area known as the gastrinoma triangle. However, they commonly occ
ur in extrapancreatic sites in multiple endocrine neoplasia type 1 syn
drome. In patients in whom Zollinger-Ellison syndrome is suspected, la
boratory evidence of hypergastrinemia and hyperacidity establishes the
diagnosis. Until the advent of proton pump inhibitors, total gastrect
omy was the treatment of choice. Therapy with these agents (eg, omepra
zole, lansoprazole) can prevent ulcer disease. However, surgical remov
al of gastrinomas offers a chance for cure and can improve longevity b
y preventing the malignant spread of the tumors.